Shionogi & Co., Ltd. (4507)

6,835.0
-15.0(-0.22%)
  • Volume:
    504,000
  • Bid/Ask:
    6,833.0/6,835.0
  • Day's Range:
    6,732.0 - 6,847.0

4507 Overview

Prev. Close
6,850
Day's Range
6,732-6,847
Revenue
291.46B
Open
6,752
52 wk Range
6,105-8,439
EPS
386.98
Volume
504,000
Market Cap
2.05T
Dividend (Yield)
120.00
(1.75%)
Average Vol. (3m)
1,691,238
P/E Ratio
15.05
Beta
0.768
1-Year Change
-9.33%
Shares Outstanding
299,294,007
Next Earnings Date
Oct 31, 2022
What is your sentiment on Shionogi?
or
Vote to see community's results!

Shionogi & Co., Ltd. News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Shionogi & Co., Ltd. Company Profile

Shionogi & Co., Ltd. Company Profile

Employees
5485
Market
Japan
  • Type:Equity
  • Market:Japan
  • ISIN:JP3347200002

Shionogi & Co., Ltd. is a Japan-based pharmaceutical company mainly engaged in the research, development, purchase, manufacture and sale of pharmaceuticals, as well as pharmaceutical-related businesses. The prescription drug business is engaged in the development of eight new drugs including hypercholesterolemia treatment drugs Crestor, antihypertensive drugs Ilbetan Family (Irbetan, Aimix, Iltra) and antidepressant drugs Sinbalta. The Company is engaged in the provision of information to contribute to medical care by maximizing its products. The over-the-counter (OTC) pharmaceutical business handles products tailored to customers' lifestyles. The in-vitro diagnostics business is engaged in the sale of products, as well as the provision of information on infectious diseases, cardiovascular diseases and allergic diseases. The Company mainly provides its products and services in Japan, Europe and North America markets.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyBuySellStrong SellBuy
Technical IndicatorsStrong BuyStrong BuySellStrong SellBuy
SummaryStrong BuyStrong BuySellStrong SellBuy
  • Pretty solid balance sheet.
    0